Telix develops and delivers precision radiopharmaceuticals for cancer care, combining diagnostics and therapy in a global theranostics platform.

Lilly develops innovative medicines in diabetes, Alzheimer’s, oncology, and immunology – with a mission to improve lives worldwide.

GE Healthcare delivers advanced medical imaging technologies and digital solutions to improve outcomes for patients and providers worldwide.

ITM develops and delivers targeted radiopharmaceuticals for cancer diagnostics and therapy to improve patient outcomes worldwide.

United Imaging provides cutting-edge imaging and therapy technologies, making high-end healthcare more accessible worldwide.

Novartis develops innovative therapies to improve and extend lives, reaching over 250 million patients worldwide.

Pars Isotope develops and supplies radioisotopes and radiopharmaceuticals with high standards in quality, safety, and global compliance.

Siemens Healthineers provides precision oncology tools that support theranostics programs across the entire care pathway.

Swiss Rockets invests in and scales innovative biotech startups through funding, mentorship, and strategic support.

IBA is a global leader in accelerator-based solutions for proton therapy, dosimetry, radiopharma, and medical device sterilization.

MIM Software provides AI-driven imaging and dosimetry tools for oncology, radiology, and nuclear medicine.

TerThera develops and produces Terbium-161 for radioligand therapy – a novel radionuclide with promising applications in cancer care.

3B Pharmaceuticals develops peptide-based radiopharmaceuticals and diagnostics for oncology with a strong focus on unmet medical needs.

ABX is a leading provider of PET and SPECT compounds, offering kits, cassettes, and GMP-grade radiopharmaceuticals.

ABX-CRO is a CRO specialising in neuroscience, oncology, and imaging, offering turnkey solutions from early studies to regulatory support.

AdvanCell develops scalable alpha radiopharmaceutical therapies, offering new hope for patients with hard-to-treat cancers.

AI4R develops real-time autoradiography systems for preclinical research, enabling high-resolution, quantitative imaging of alpha and beta emitters.

AXIM supplies diagnostic and therapeutic nuclear medicine solutions across Sub-Saharan Africa, with over 20 years of regional expertise.

Cardinal Health offers medical products and efficiency solutions to healthcare providers worldwide – from logistics to surgical and cardiovascular care.

CheMatech designs and supplies custom and catalog chelators for imaging and therapy, with rapid delivery and over 30 years of experience.

CMR supplies radionuclides and isotopes for nuclear medicine, research, and industry—globally connected, innovative, and reliable.

COMECER develops advanced containment and isolation systems for pharma, radiopharma, and ATMPs – trusted worldwide for sterile and high-precision environments.

Curium Nükleer Tıp A.S. develops and supplies GMP radiopharmaceuticals globally and is one of the world’s major producers of lutetium.

ICPO is building a global network of certified centers to expand access to Radiomolecular Precision Oncology through standards, education, and collaboration.

Molecular Partners develops DARPin® therapeutics, a new class of custom-built drugs designed to tackle cancer and other serious diseases.

PanTera enables large-scale production of actinium-225 to support future alpha-based cancer therapies and radiotheranostics.

Perspective Therapeutics develops Pb-212–based targeted alpha therapies and theranostic platforms for highly selective cancer treatment.

RQS offers expert support in radiochemistry, GMP production, and chromatography – with teams in Europe and the USA.

SHINE uses fusion technology to produce medical isotopes, enable neutron imaging, and build a path toward carbon-free energy.

Tema Sinergie offers advanced systems for nuclear medicine, pharma isolation, and radiotherapy – combining innovation with personalized support.

TrisKem supplies selective resins and QC materials for the separation and control of medical radionuclides and generator products.

Von Gahlen provides reliable shielding systems and equipment for nuclear medicine – engineered for safety, precision, and long-term partnership.